The Quality Longevity Company
Powered by a Prediction Markets Treasury
One Ticker. Two Engines
Clinical Engine
Allocetra™ is a clinical-stage immunotherapy targeting age-related knee osteoarthritis, designed to restore mobility, independence, and quality of life in aging populations.
Treasury Engine
Enlivex anchors its reserves in Rain, a leading prediction markets protocol on Arbitrum, with fee-linked buyback mechanics tied to network activity.
A Clinical Asset
for Quality Longevity
Allocetra™ is a macrophage reprogramming therapy targeting age-related knee osteoarthritis — a $314B longevity market.
Phase II clinical data demonstrated:
- 72% reduction in pain
- 109% improvement in function
- Favorable safety profile across 250+ treated patients
Our focus is not simply extending years, but restoring mobility, independence, and functional life.
Learn More
Market Snapshot
Real-time public-market indicators for
ENLV and RAIN exposure.
The Prediction
Markets Treasury
Enlivex anchors its reserves in RAIN, a decentralized prediction markets protocol built as infrastructure - not a single trading platform.
As trading activity flows through the network, its economic model is designed to reflect real usage.
Rather than holding a passive token, our treasury exposure is connected to the growth and activity of the protocol.
Public-Market Access
Exposure to prediction market infrastructure via Nasdaq-listed equity.
Capital Structure Discipline
A treasury model designed to reduce reliance on repeated equity dilution.
Value Linked to Rain Network Activity
Treasury exposure tied to Rain protocol usage — not sentiment alone.